HRMY

insider transactions

Harmony Biosciences Holdings, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
May 14, 26

Ron M Philip

Director

$0

21.9K sh

Own New
Grant·A
May 14, 26

Juan A. Sabater

Director

$0

21.9K sh

Own New
Grant·A
May 14, 26

Linda M Szyper

Director

$0

21.9K sh

Own New
Grant·A
May 14, 26

Gary Sender

Director

$0

21.9K sh

Own New
Exercise·M
May 1, 26

Kumar Budur

CHIEF MEDICAL OFFICER

$0

18.8K sh

Own +100%
Other·F
May 1, 26

Kumar Budur

CHIEF MEDICAL OFFICER

$282.7K

8.9K sh · $31.83

Own -27%
Exercise·M
May 1, 26

Kumar Budur

CHIEF MEDICAL OFFICER

$0

18.8K sh

Own +132%
Grant·A
Apr 14, 26

Glenn Reicin KEY

CHIEF FINANCIAL OFFICER

$0

164.3K sh

Own New
Exercise·M
Apr 7, 26

Adam H. Zaeske

CHIEF COMMERCIAL OFFICER

$0

7.5K sh

Own New
Other·F
Apr 7, 26

Adam H. Zaeske

CHIEF COMMERCIAL OFFICER

$87.6K

3.2K sh · $27.62

Own -42%
Exercise·M
Apr 7, 26

Adam H. Zaeske

CHIEF COMMERCIAL OFFICER

$0

7.5K sh

Own New
Grant·A
Apr 2, 26

Troy A. Ignelzi

Director

$0

17.7K sh

Own New
Grant·A
Apr 2, 26

Peter Anastasiou

CHIEF OPERATING OFFICER

$0

212.2K sh

Own New

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
May 14, 2026	Ron M Philip	Director	Grant A	21.9K	New	—	$0
May 14, 2026	Juan A. Sabater	Director	Grant A	21.9K	New	—	$0
May 14, 2026	Linda M Szyper	Director	Grant A	21.9K	New	—	$0
May 14, 2026	Gary Sender	Director	Grant A	21.9K	New	—	$0
May 1, 2026	Kumar Budur	CHIEF MEDICAL OFFICER	Exercise M	18.8K	+100%	—	$0
May 1, 2026	Kumar Budur	CHIEF MEDICAL OFFICER	Other F	8.9K	-27%	$31.83	$282.7K
May 1, 2026	Kumar Budur	CHIEF MEDICAL OFFICER	Exercise M	18.8K	+132%	—	$0
Apr 14, 2026	Glenn Reicin KEY	CHIEF FINANCIAL OFFICER	Grant A	164.3K	New	—	$0
Apr 7, 2026	Adam H. Zaeske	CHIEF COMMERCIAL OFFICER	Exercise M	7.5K	New	—	$0
Apr 7, 2026	Adam H. Zaeske	CHIEF COMMERCIAL OFFICER	Other F	3.2K	-42%	$27.62	$87.6K
Apr 7, 2026	Adam H. Zaeske	CHIEF COMMERCIAL OFFICER	Exercise M	7.5K	New	—	$0
Apr 2, 2026	Troy A. Ignelzi	Director	Grant A	17.7K	New	—	$0
Apr 2, 2026	Peter Anastasiou	CHIEF OPERATING OFFICER	Grant A	212.2K	New	—	$0

About HRMY insider trading

This page tracks insider transactions for Harmony Biosciences Holdings, Inc. (HRMY) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.